Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology)

American Journal of Cardiology

Volumn 84, Issue 3, 1999, Pages 339-341

  Esselstyn Jr , Caldwell B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIPID;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CULTURAL FACTOR; DIETARY INTAKE; DISEASE COURSE; FEMALE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; LOW FAT DIET; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTILIPEMIC AGENTS; CHOLESTEROL; CORONARY DISEASE; DIET, VEGETARIAN; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0344132034     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00290-8     Document Type: Article

References (20)

1. Forrester J.S., Shah P.K. Lipid lowering versus revascularization - an idea whose time for testing has come. Circulation. 96:1997;1360-1362.
2. Ambrose J.A., Fuster V. Can we predict future coronary events in patients with stable coronary artery disease? JAMA. 277:1997;343-344.
3. Kesteloot H., Huang D.X., Yang X.S., Claes J., Rosseneu M., Geboers J., Joossens J.V. Serum lipids in the People's Republic of China. Comparison of Western & Eastern populations. Arteriosclerosis. 5:1985;427-433.
4. Campbell T.C., Parpia B., Chen J. Diet, lifestyle and the etiology of coronary artery disease The Cornell China Study . Am J Cardiol. 82:(suppl):1998;18T-21T.
5. Castelli W. Take this letter to your doctor. Prevention. 48:1966;61-64.
6. Castelli W.P., Doyle J.T., Gordon T., Hames C.G., Hjortland M.C., Hulley S.B., Kagan A., Zukel W.J. HDL cholesterol and other lipids in coronary heart disease the Cooperative Lipoprotein Phenotyping Study . Circulation. 55:1977;767-772.
7. Blankenhorn D.H., Nessim H.A., Johnson R.L., Sanmarco M.E., Azen S.P., Cashan-Hempill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 257:1987;3233-3240.
8. Gould A.L., Rossouw J.E., Santanello N.C., Heyse J.F., Furberg C.D. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation. 91:1995;2274-2282.
9. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. The Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 279:1998;1615-1622.
10. Braunwald E. Shattuck lecture Cardiovascular medicine at the turn of the millennium: triumphs, concerns and opportunities . N Engl J Med. 337:1997;1360-1369.
11. Tu J.V., Pashos C.L., Naylor C.D., Chen E., Normand S.L., Newhouse J.P., McNeil B.J. Use of cardiac procedures and outcomes in the elderly patients with myocardial infarction in the United States and Canada. N Engl J Med. 336:1997;1500-1505.
12. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 335:1996;217-225.
13. Topol E.J. Coronary artery stents - gauging, gorging, and gouging. N Engl J Med. 339:1998;1702-1703.
14. Esselstyn C.B. Jr, Ellis S.G., Medendorp S.V., Crowe T.D. A strategy to arrest and reverse coronary artery disease a 5-year longitudinal study of a single physician's practice . J Fam Prac. 41:1995;560-568.
15. Roberts W.C. Atherosclerotic risk factors - are there ten or is there only one? Am J Cardiology. 64:1989;552-554.
16. Ornish D., Brown S.E., Scherwitz L.W., Billings J.H., Armstrong W.T., Ports T.A., McLanahan S.M., Kirkeeide R.L., Brand R.J., Gould K.L. Can lifestyle changes reverse coronary artery disease? The Lifestyle Heart Trial. Lancet. 336:1990;129-133.
17. Watts G.F., Lewis B., Brunt J.N., Lewis E.S., Coltart D.J., Smith L.D., Mann J.I., Swan A.V. Effects on coronary artery disease of lipid lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerotic Regression Study (STARS). Lancet. 339:1992;563-569.
18. Ornish D., Scherwitz L.W., Billings J.H., Gould K.L., Merritt T.A., Sparler S., Armstrong W.T., Ports T.A., Kirkeeide R.L., Hogeboom C., Brand R.J. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 280:1998;2001-2007.
19. Lichtenstein A.H., Van Horn L. Very low fat diets. Circulation. 98:1998;935-939.
20. Diet and health implications for reducing chronic disease risk/Committee on Diet and Health, Food and Nutrition Board, Commission on Life Sciences, National Research Council . 1989;National Academy Press, Washington, DC.